arrow
T

Troels Thim

Aarhus University
H指数:29
被引数:5,081

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design and rationale of the COMPARE-TAVI 2 trial: An all-comers head-to-head comparison of Evolut FX+ and Sapien 3 Ultra Resilia transcatheter heart valves

COMPARE-TAVI 2试验的设计与原理:Evolut FX+和Sapien 3 Ultra Resilia经导管心脏瓣膜的全面直接比较研究

2026-02-230
OAAI
Cardiac damage and outcome in transcatheter aortic valve replacement patients-a COMPARE-TAVI 1 trial sub-study

经导管主动脉瓣置换患者的心脏损伤与预后——COMPARE-TAVI 1试验亚组研究

2025-12-010
PRE
Impact of Flow-status on Effective Orifice Area in Transcatheter Heart Valves: a COMPARE-TAVI 1 Substudy

经导管心脏瓣膜中血流状态对有效瓣口面积的影响:COMPARE-TAVI 1 子研究

2025-10-040
PRE
Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction

心肌梗死的立即或延迟非罪犯病变PCI

2025-10-012
PRE
Biolimus-Eluting Biomatrix Stent vs a Dual-Therapy Sirolimus-Eluting Stent in PCI

Biolimus-Eluting Biomatrix Stent 与 Dual-Therapy Sirolimus-Eluting Stent 在 PCI 中的比较

2025-05-210
PRE
Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in patients treated with percutaneous coronary intervention: the three-year outcomes of the SORT OUT X randomised clinical trial
2023-10-010
PRE
Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation

心房颤动患者经皮冠状动脉介入治疗后1年以上的抗栓治疗

2022-10-213
PRE
Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody- Covered SirolimusEluting Combo Stent With the SirolimusEluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention The SORT OUT X Trial

双重治疗CD34抗体覆盖的sirolimus洗脱组合支架与sirolimus洗脱Orsiro支架在经皮冠状动脉介入治疗患者中的随机临床比较

2021-06-0130
OA